Determinants of use of oral complementary-alternative medicine among women with early breast cancer: a focus on cancer-related fatigue

[1]  É. Minvielle,et al.  Unhealthy behaviors after breast cancer: Capitalizing on a teachable moment to promote lifestyle improvements , 2021, Cancer.

[2]  A. Zare Javid,et al.  Ginseng and Cancer-Related Fatigue: A Systematic Review of Clinical Trials , 2020, Nutrition and cancer.

[3]  N. Lin,et al.  Serum Detection of Nonadherence to Adjuvant Tamoxifen and Breast Cancer Recurrence Risk , 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  J. Huebner,et al.  Recommendations on complementary and alternative medicine within S3 guidelines in oncology: systematic quality assessment of underlying methodology , 2020, Journal of Cancer Research and Clinical Oncology.

[5]  M. Lucijanić,et al.  Dietary Supplement Use and Patient Outcomes in High-Risk Early-Stage Breast Cancer. , 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  F. Roila,et al.  Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatment. , 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  M. Freissmuth,et al.  Against all odds—the persistent popularity of homeopathy , 2020, Wiener klinische Wochenschrift.

[8]  Lara E Sucheston-Campbell,et al.  Dietary Supplement Use During Chemotherapy and Survival Outcomes of Patients With Breast Cancer Enrolled in a Cooperative Group Clinical Trial (SWOG S0221). , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  F. André,et al.  UNICANCER: French prospective cohort study of treatment-related chronic toxicity in women with localised breast cancer (CANTO) , 2019, ESMO Open.

[10]  I. Kleckner,et al.  Nutritional Interventions for Treating Cancer-Related Fatigue: A Qualitative Review , 2019, Nutrition and cancer.

[11]  A. Hapfelmeier,et al.  Evaluating the Demand for Integrative Medicine Practices in Breast and Gynecological Cancer Patients , 2018, Breast Care.

[12]  G. Lyman,et al.  Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the SIO Clinical Practice Guideline Summary. , 2018, Journal of oncology practice.

[13]  A. DeMichele,et al.  Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the SIO Clinical Practice Guideline. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  C. Gross,et al.  Use of Alternative Medicine for Cancer and Its Impact on Survival. , 2017, Journal of the National Cancer Institute.

[15]  S. Zick,et al.  Clinical practice guidelines on the evidence‐based use of integrative therapies during and after breast cancer treatment , 2017, CA: a cancer journal for clinicians.

[16]  R. Baumgartner,et al.  Use of complementary and alternative medicine and breast cancer survival in the Health, Eating, Activity, and Lifestyle Study , 2016, Breast Cancer Research and Treatment.

[17]  A. Neugut,et al.  Association Between Complementary and Alternative Medicine Use and Breast Cancer Chemotherapy Initiation: The Breast Cancer Quality of Care (BQUAL) Study. , 2016, JAMA oncology.

[18]  G. Sampaio,et al.  Bioavailability of catechins from guaraná (Paullinia cupana) and its effect on antioxidant enzymes and other oxidative stress markers in healthy human subjects. , 2016, Food & function.

[19]  A. Trentham-Dietz,et al.  Partnership Status and Socioeconomic Factors in Relation to Health Behavior Changes after a Diagnosis of Ductal Carcinoma In Situ , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[20]  A. Trentham-Dietz,et al.  Health behavior change following a diagnosis of ductal carcinoma in situ: An opportunity to improve health outcomes. , 2015, Preventive medicine.

[21]  M. Frass.  Influence of Adjunctive Classical Homeopathy on Global Health Status and Subjective Well-Being in Cancer Patients: A Pragmatic Randomized Controlled Trial , 2015, Homeopathy.

[22]  J. Bower,et al.  Cancer-related fatigue—mechanisms, risk factors, and treatments , 2014, Nature Reviews Clinical Oncology.

[23]  G. Lyman,et al.  Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical oncology clinical practice guideline adaptation. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  J. Huebner,et al.  Online Survey of Cancer Patients on Complementary and Alternative Medicine , 2014, Oncology Research and Treatment.

[25]  M. Fitch,et al.  Factors influencing adherence to cancer treatment in older adults with cancer: a systematic review. , 2014 .

[26]  D. Elbourne,et al.  Systematic review of the Hawthorne effect: New concepts are needed to study research participation effects☆ , 2014, Journal of clinical epidemiology.

[27]  J. Huebner,et al.  Survey of German Non-Medical Practitioners Regarding Complementary and Alternative Medicine in Oncology , 2014, Oncology Research and Treatment.

[28]  A. Giglio,et al.  Purified Dry Extract of Paullinia cupana (Guaraná) (PC-18) for Chemotherapy-Related Fatigue in Patients with Solid Tumors: An Early Discontinuation Study , 2013, Journal of dietary supplements.

[29]  J. Sloan,et al.  Wisconsin Ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2. , 2013, Journal of the National Cancer Institute.

[30]  A. Molassiotis,et al.  A Systematic Review of Complementary and Alternative Medicine Interventions for the Management of Cancer-Related Fatigue , 2013, Integrative cancer therapies.

[31]  R. Riechelmann,et al.  Guarana (Paullinia cupana) improves fatigue in breast cancer patients undergoing systemic chemotherapy. , 2011, Journal of alternative and complementary medicine.

[32]  A. Molassiotis,et al.  A systematic review of complementary and Alternative medicine interventions in the management of cancer-related fatigue , 2011, BMJ Supportive & Palliative Care.

[33]  S. Vollset,et al.  Cancer incidence and mortality after treatment with folic acid and vitamin B12. , 2009, JAMA.

[34]  A. Vickers,et al.  Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? , 2008, Journal of the National Cancer Institute.

[35]  J. Farrar,et al.  Use of complementary and alternative medicine and prayer among a national sample of cancer survivors compared to other populations without cancer. , 2007, Complementary therapies in medicine.

[36]  Marjan Jahanshahi,et al.  The Validity of the Hospital Anxiety and Depression Scale and the Geriatric Depression Scale in Parkinson’s Disease , 2006, Behavioural neurology.

[37]  P. Ganz,et al.  Fatigue in long‐term breast carcinoma survivors , 2006, Cancer.

[38]  Julia A Scott,et al.  Complementary and alternative medicine use in breast cancer patients in Europe , 2006, Supportive Care in Cancer.

[39]  A. Vickers,et al.  High prevalence of complementary and alternative medicine use among cancer patients: implications for research and clinical care. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  M. Kosty.  PC-SPES: hope or hype? , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  R. Livingston,et al.  Potential of chemotherapy–herb interactions in adult cancer patients , 2004, Supportive Care in Cancer.

[42]  J. Nicholl,et al.  A randomised, controlled, triple-blind trial of the efficacy of homeopathic treatment for chronic fatigue syndrome. , 2004, Journal of psychosomatic research.

[43]  D. Redelmeier,et al.  A Comparison of Risk Perception and Psychological Morbidity in Women with Ductal Carcinoma in situ and Early Invasive Breast Cancer , 2003, Breast Cancer Research and Treatment.

[44]  J. Brisson,et al.  Dietary change after breast cancer: extent, predictors, and relation with psychological distress. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[45]  T. T. Haug,et al.  The validity of the Hospital Anxiety and Depression Scale. An updated literature review. , 2002, Journal of psychosomatic research.

[46]  D. Tripathy,et al.  Complementary and alternative medicine in early-stage breast cancer. , 2001, Seminars in oncology.

[47]  M. Wrensch,et al.  Alternative therapies used by women with breast cancer in four ethnic populations. , 2000, Journal of the National Cancer Institute.

[48]  E. Guadagnoli,et al.  Use of alternative medicine by women with early-stage breast cancer. , 1999, The New England journal of medicine.

[49]  R. Gray,et al.  Physician Perspectives on Unconventional Cancer Therapies , 1997, Journal of palliative care.

[50]  N. Aaronson,et al.  The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[51]  C. Vincent,et al.  The health beliefs and behaviors of three groups of complementary medicine and a general practice group of patients. , 1995, Journal of alternative and complementary medicine.

[52]  D. Osoba,et al.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.

[53]  R. Snaith,et al.  The Hospital Anxiety And Depression Scale , 2003, Health and quality of life outcomes.

[54]  G. Huston.  The Hospital Anxiety and Depression Scale. , 1987, The Journal of rheumatology.

[55]  J. V. Wood,et al.  Attributions, beliefs about control, and adjustment to breast cancer. , 1984, Journal of personality and social psychology.